Sunshine Biopharma Inc. - Common stock (SBFM)

Competitors to Sunshine Biopharma Inc. - Common stock (SBFM)

AquaBounty Technologies, Inc.

AquaBounty is focused on genetic innovations in aquaculture, which parallels Sunshine Biopharma's efforts in biopharmaceuticals. Both companies are engaged in developing advanced technologies to enhance product efficacy and reduce costs within their respective sectors. While Sunshine Biopharma deals with drug development, especially in cancer treatments, AquaBounty leverages biotechnology for improved fish farming. Their competition is primarily in the realms of innovation and patent protections in biotechnological advancements.

CTI BioPharma Corp.

CTI BioPharma specializes in developing therapies for blood-related cancers, similar to Sunshine Biopharma's focus on oncology. The competition lies in therapeutic target areas and drug effectiveness. CTI has achieved some commercial successes and has a focused product pipeline, which might provide it with a competitive edge over Sunshine Biopharma, whose pipeline is still developing. This ability to bring products to market faster allows CTI to secure a stronger foothold in the cancer treatment industry.

OncoSec Medical Incorporated

OncoSec Medical is involved in developing intratumoral immunotherapies for cancer, vying for a similar patient demographic as Sunshine Biopharma. Both companies aim to innovate in cancer treatment; however, OncoSec’s differentiated approach and stage of clinical trials provide it with a leading edge. Their advanced clinical development and collaborations in research allow them to establish a more robust market position in immunotherapy, a noteworthy strategic area in cancer treatment.

Puma Biotechnology, Inc. 

Puma Biotechnology focuses on the development of innovative cancer therapies, which directly competes with Sunshine Biopharma's offerings. Both companies target oncology markets but may engage in different specifics regarding drug mechanisms and clinical developments. Puma has established a solid market presence with its FDA-approved products, giving it a competitive edge over Sunshine Biopharma, who is still in earlier stages of development. This market experience and product availability give Puma a notable advantage.